1SXP fundamentals
An in-depth look to SCHOTT PHARMA AG & CO. KGAA operating, investing, and financing activities
1SXP free cash flow for Q4 24 is 11.42 M EUR. For 2024, 1SXP free cash flow was 80.25 M EUR and operating cash flow was 225.33 M EUR.
Q4 '22
Q1 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q4 '22
Q1 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM